Aveir DR i2i Study
NCT: NCT05252702 · COMPLETED
NCT IDNCT05252702
StatusCOMPLETED
Start Date2022-02-02
Completion2026-02-03
Brief Summary
Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.
Frequently Asked Questions
What is Aveir DR i2i Study?
Aveir DR i2i Study is a clinical trial registered under NCT05252702. Current status: COMPLETED.
What is the status of NCT05252702?
The current status of NCT05252702 (Aveir DR i2i Study) is: COMPLETED.
When did Aveir DR i2i Study start?
Aveir DR i2i Study started on 2022-02-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.